Form 8-K - Current report:
SEC Accession No. 0000950170-25-035943
Filing Date
2025-03-10
Accepted
2025-03-10 08:35:07
Documents
11
Period of Report
2025-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20250307.htm   iXBRL 8-K 44997
  Complete submission text file 0000950170-25-035943.txt   160753

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20250307.xsd EX-101.SCH 25787
13 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20250307_htm.xml XML 4709
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 25722287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)